Synthesis and antibacterial profile of novel azomethine derivatives of β-phenylacrolein moiety by Chigurupati, Sridevi et al.
Chigurupati et al 
Trop J Pharm Res, April 2016; 15(4): 821  
 
Tropical Journal of Pharmaceutical Research April 2016; 15 (4): 821-826 
ISSN: 1596-5996 (print); 1596-9827 (electronic) 
© Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria.  
All rights reserved. 
 
Available online at http://www.tjpr.org 
http://dx.doi.org/10.4314/tjpr.v15i4.22 
Original Research Article 
 
 
Synthesis and antibacterial profile of novel azomethine 
derivatives of β-phenylacrolein moiety 
 
Sridevi Chigurupati1*, Neeraj Kumar Fuloria1, Shivkanya Fuloria1, Sundram 
Karupiah1, Ravichandran Veerasamy1, Appala Raju Nemala2,  Lim Jun Yi1, Ang 
xiang Ilan1 and Syed Adnan Ali Shah3 
1AIMST University, Faculty of Pharmacy, Semeling, 08100 Bedong, Kedah, Malaysia, 2Department of Pharmaceutical 
chemistry, Sultan–Ul–Uloom College of Pharmacy, Road No. 3, Banjara hills, Hyderabad, India, 3Universiti Teknologi MARA 
(UiTM), Faculty of Pharmacy, Puncak Alam Campus, Selangor D.E, Malaysia 
 
*For correspondence: Email: sridevi.phd@gmail.com; Tel: +6-014-9449846 
 
Received: 16 December 2015        Revised accepted: 24 March 2016 
 
Abstract 
Purpose: To develop some novel molecules effective against antibiotic-resistant bacterial infections.   
Methods: A series of azomethines (SB-1 to SB-6) were synthesized from β-phenyl acrolein moiety. The 
structures of the synthesized compounds were confirmed on the basis of their UV ultra-violet (UV) 
spectroscopy (λmax: 200 - 400 nm), Fourier transform infra-red (FTIR, vibrational frequency: 500-4000 
cm-1), 1H nuclear magnetic resonance (NMR, chemical shift: 0 - 10 ppm), 13C NMR (chemical shift: 0 - 
200 ppm), mass spectrometry (m/z values: 0 - 500) and carbon hydrogen nitrogen (CHN) elemental 
analysis. The new compounds were screened for antibacterial activity by test-tube dilution and disc 
diffusion methods using gentamicin as reference standard. 
Results: The structures of azomethine were in full agreement with their spectral data. Among all the 
synthesized compounds, compounds SB-5 and SB-6 exhibited the highest minimum inhibitory 
concentration (MIC) of 62.5 µg/mL. At MIC of 250 µg/mL, all compounds SB-1 to SB-6 displayed 
significant antibacterial activity, compared to gentamycin (p < 0.05). SB-5 and SB-6 were active against 
S. aureus, P. aeruginosa and K. pneumoniae; SB-3 was active against B. subtilis and S. aureus. SB-4 
was active against P. aeruginosa and S. aureus while SB-1 and SB-2 were active against S. aureus. 
Conclusion: The synthesized compounds possess antibacterial activities compared to those of 
gentamycin.  
 
Keywords: Acrolein, Imines, Azomethine, Antibacterial, Gentamycin, Minimum inhibitory concentration 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Antimicrobial drugs occupy a unique niche in the 
history of medicine. The increased incidence of 
severe opportunistic bacterial infections in 
immunological deficient patients together with the 
development of resistance among pathogenic 
Gram-positive and Gram-negative bacteria have 
revealed great need to search for new 
compounds that are effective against antibiotic-
resistant bacteria. Literature highlights the 
potentials of β-phenyl acrolein as an 
antimicrobial [1], anticancer [2] and flavoring 
agent for chewing gums [3]. Many investigators 
have observed the importance of azomethines 
for their antibacterial [4,5] antifungal [6], anti-
proliferative [7,8] and antipyretic properties. It is 
evident that azomethines with aryl substituents 
are more stable and readily synthesized, 
whereas those containing alkyl substituents are 
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relatively unstable. Azomethines of aliphatic 
aldehydes are usually unstable and readily 
polymerizable, while those with aromatic 
aldehydes having effective conjugation are more 
stable [9]. 
 
In the present research work, a new series of 
azomethine derivatives of β-phenyl acrolein was 
synthesized (SB-1 to SB-6) and screened for 
antibacterial activity against Gram-positive 
(Bacillus subtilis and Staphylococcus aureus) 
and Gram-negative (Klebsiella pneumonia and 
Pseudomonas aeruginosa) bacteria in order to 






All the solvents and chemicals used were of 
analytical grade and obtained from Sigma-Aldrich 
and Merck Pvt Ltd, India and were used without 
further purification. 
 
General procedure for synthesis of 
azomethine derivatives of β-phenyl acrolein 
 
Equimolar concentration of β-phenyl acrolein 
(0.01 M) and substituted aromatic amines (0.01 
M) were dissolved in 50 mL of anhydrous ethanol 
separately. Solution of substituted aromatic 
amine was then added drop-wise into β-phenyl 
acrolein solution in a conical flask. The mixture 
was made up to 150 mL with 95 % anhydrous 
ethanol, and 2 to 3 drops of triethylamine (basic 
catalyst) was added [10].The mixture was then 
stirred using magnetic stirrer at 60 to 70 °C for 6 
h over a water bath. The reaction was monitored 
by TLC. The sample mixture was evaporated 
under pressure at 65 °C using rotatory 
evaporator [11,12]. The solid obtained on 
concentration of filtrate was recrystallized from 
aqueous ethanol to yield the pure compounds 
SB-1 to SB-6 (physical data are given in Table 
1). The melting points of the compounds were 
determined on a Thoshniwal electric melting 
point apparatus and the values were 
uncorrected. The reaction was mentioned by 
TLC on Silica gel-GF 254 (Merck) coated plates. 
Spots of TLC were identified in iodine chamber. 
 
Determination of minimum inhibitory 
concentration (MIC) 
 
Test tube dilution method was used to determine 
minimum inhibitory concentration. One mL of 
sterilized media (Nutrient agar) was poured into 
sterile test tubes. One mL of 2000 µg/mL test 
solution was transferred in one tube and serially 
diluted to give concentrations of 1000, 500, 250 
and 125 µg/mL. To all the test tubes, 0.1 mL of 
suspension of bacteria in saline was added and 
the tubes were incubated at 37 °C for 24 h. The 
growth in the tubes was observed visually for 
turbidity. MIC was determined with the lowest 
concentration of the sample that retarded the 
development of turbidity [13].  
 
Table 1: Physical data for azomethine derivatives of β-







SB-1 C15H13N Yellow 0.43 
SB-2 C16H13NO White 0.50 
SB-3 C15H13NO White 0.56 
SB-4 C16H15NO Yellow 0.62 
SB-5 C17H15NO3 Brown 0.54 




The disc diffusion method [14,15] was used to 
determine the antibacterial activity of azomethine 
using a 6-mm disc were prepared from 
Whatman’s filter paper no.1. Azomethine 
solutions of varying concentrations ranging from 
125, 250 and 500 µg/mL were prepared. Nutrient 
agar was prepared, sterilized and used as the 
growth medium for the culture of 
microorganisms; 20 mL of the sterilized medium 
was poured into each sterilized petri dish, 
covered and allowed to solidify. Thereafter, the 
16-h old broth cultures of the specified 
microorganisms were used for disc diffusion 
studies [13].The sample, control and standard 
treated discs were air-dried at room temperature, 
to remove any residual solvent which might 
interfere with the determination, sterilized and 
inoculated. These plates were initially placed at 
low temperature for 1 h to allow the maximum 
diffusion of compounds from the test disc into the 
agar plate and later incubated at 37 °C for 24 h 
in case bacteria [16],  after which the zone of 




Each experimental value is expressed as the 
mean ± standard error mean (n = 3). Statistical 
analysis was performed using GraphPad Prism 
5.0 and data analyzed using one-way analysis of 
variance (ANOVA) for comparison between 
groups followed by Dunnett's multiple 






UV-Visible, IR, NMR and mass spectral data 
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 supported the structures of all newly synthesized 
compounds. The spectral data for the newly 
synthesized compounds are as follows. 
  
N-(3-phenylallylidene)benzamine (SB-1): 
Yield: 70 %; mp: 98-100 ºC; Anal. Calcd. for 
C15H13N: C, 86.92; H, 6.32; N, 6.76 %. Found C, 
86.89; H, 6.28; N, 6.66 %; IR (KBr, cm-1): 3085 
(=C-H stretching of aromatic ring), 3039 (=C-H 
stretching of alkenyl group), 1600 (-C=N 
stretching azomethine group), 1540-1600 (C=C- 
stretching of aromatic ring), 1320 (C-N, 
stretching of azomethine group); 1H-NMR (500.1 
MHz, CDCl3-d, δ/ppm): 5.76 (1H, t,J = 9.5 Hz, H-
2'), 6.52 (1H, d,J = 12 Hz, H-3'), 7.23 - 7.60 
(10H, m, phenyl), 8.24 (1H, d,J = 7.8 Hz, H-1'); 
13C-NMR (100 MHz, CDCl3, δ / ppm): 120.2 (C2'), 
123.4 (C3& C5), 126.3 (C5'& C9'), 127.5 (C1), 
128.4 (C7'), 129.2 (C6'& C8'), 131.1 (C2& C6), 
135.8 (C4'), 139.2 (C3'), 150.4 (C4), 164.3 (C1'); 
MS (m/z, (relative abundance, %)): 207 (M+, 
18.9), 107, 102, 77, 53, 51, 130 (BP, 100); UV-
Vis (MeOH) (max/nm): 353.  
 
4-(3-Phenylallylideneamino)benzaldehyde 
(SB-2): Yield: 79 %; mp: 130-134 ºC; Anal. 
Calcd. for C16H13NO: C, 81.68; H, 5.57; N, 5.95 
%. Found C, 81.56; H, 5.48; N, 5.87 %; IR (KBr, 
cm-1): 3050 (=C-H stretching of aromatic ring), 
3038 (=C-H stretching of alkenyl group), 2720, 
2820 (C-H  stretching of aldehyde group), 1725 
(C=O Stretching of aldehyde group), 1658 (-C=N 
stretching azomethine group), 1540-1620 (C=C- 
stretching of aromatic ring), 1320 (C-N, 
stretching of azomethine group); 1H-NMR (500.1 
MHz, CDCl3-d, δ/ppm): 5.81 (1H, t, J = 9.5 Hz, H-
2'), 6.63 (1H, d, J = 12 Hz, H-3'), 7.5 - 7.9 (10H, 
m, phenyl), 8.32 (1H, d, J = 7.8 Hz, H-1'), 9.94 (s, 
1H, aldehyde); 13C-NMR (100 MHz, CDCl3, δ / 
ppm): 120.5 (C2'), 123.8 (C3& C5), 126.2 (C5'& 
C9'), 128.3 (C7'), 129.4 (C6'& C8'), 131.8 (C2& C6), 
135.4 (C4'), 136.3 (C1), 139.6 (C3'), 155.2 (C4), 
164.6 (C1'), 192.4 (-CHO); MS (m/z, (relative 
abundance, %)):  235 (M+, 20.4), 158, 105, 102, 




Yield: 80 %; mp: 120-130 ºC; Anal. Calcd. for 
C15H13NO: C, 80.69; H, 5.87; N, 6.27 %. Found 
C, 80.56; H, 5.78; N, 5.82 %; IR (KBr, cm-1): 
3640 (Broad, O-H Str), 3055 (=C-H stretching of 
aromatic ring), 3038 (=C-H stretching of alkenyl 
group), 1668 (-C=N stretching azomethine 
group), 1540-1600 (C=C- stretching of aromatic 
ring), 1320 (C-N, stretching of azomethine 
group); 1H-NMR (500.1 MHz, CDCl3-d, δ/ppm): 
5.4 (1H, s, -OH, D2O exchangeable), 5.72 (1H, t, 
J = 9.5 Hz, H-2'), 6.59 (1H, d,J = 12 Hz, H-3'), 
7.4 - 7.8 (10H, m, phenyl), 8.29 (1H, d,J = 7.8 
Hz, H-1'); 13C NMR (100 MHz, CDCl3, δ / ppm): 
118.4 (C2& C6), 120.3 (C2'), 123.9 (C3& C5), 
126.5 (C5'& C9'), 128.4 (C7'), 129.2 (C6'& C8'), 
135.8 (C4'), 139.2 (C3'), 141.6 (C4), 157.2 (C1), 
164.3 (C1'); MS (m/z, (relative abundance, %)): 
223 (M+, 18.5), 146, 130, 102, 93, 77, 53, 51 
(BP, 100); UV-Vis (MeOH) (max/nm): 302. 
 
4-Methoxy-N-(3-phenylallylidene)benzamine 
(SB-4): Yield: 87 %; mp: 140-143 ºC; Anal. 
Calcd. for C16H15NO: C, 80.98; H, 6.37; N, 5.90 
%. Found C, 80.96; H, 6.33; N, 4.89 %; 80.59; IR 
(KBr, cm-1): 3052 (=C-H stretching of aromatic 
ring), 3037 (=C-H stretching of alkenyl group), 
2934, 2876 (C-H, Str), 1658 (-C=N stretching 
azomethine group), 1540-1620 (C=C- stretching 
of aromatic ring), 1320 (C-N, stretching of 
azomethine group), 1255 (C-O-C, Str); 1H-NMR 
(500.1 MHz, CDCl3-d, δ/ppm): 3.73 (3H, s, CH3), 
5.74 (1H, t, J = 9.5 Hz, H-2'), 6.56 (1H, d, J = 12 
Hz, H-3'), 7.3 - 7.75 (10H, m, phenyl), 8.36 (1H, 
d, J = 7.8 Hz, H-1'); 13C-NMR (100 MHz, CDCl3, 
δ / ppm): 56.3 (-CH3), 116.2 (C3& C5), 120.4 
(C2'), 123.7 (C3& C5), 126.2 (C5'& C9'), 126.9 (C7'), 
128.1 (C6'& C8'), 135.8 (C4'), 139.3 (C3'), 141.2 
(C4), 160.4 (C1), 164.3; MS (m/z, (relative 
abundance, %)): 237 (M+, 19.0), 160, 130, 107, 




phenylallylideneamino)benzoic acid (SB-5): 
Yield: 80 %; mp: 150-154 ºC; Anal. Calcd. for 
C17H15NO3: C, 72.58; H, 5.37; N, 4.98 %. Found 
C, 72.52; H, 5.39; N, 4.92 %; IR (KBr, cm-1): 
3400-2500 (OH Str of COOH), 3057 (=C-H 
stretching of aromatic ring), 3038 (=C-H 
stretching of alkenyl group), 2500-2900 (O-H of 
COOH, Str),  1720 (C=O of COOH Str), 1658 (-
C=N stretching azomethine group), 1540-1620 
(C=C- stretching of aromatic ring), 1280 (C-O 
stretching of COOH group), 1323 (C-N, 
stretching of azomethine group), 1250 (C-O-C 
stretching of ether group); 1H-NMR (500.1 MHz, 
CDCl3-d, δ/ppm): 3.74 (3H, s, OCH3), 5.76 (1H, 
t,J = 9.5 Hz, H-2'), 6.8 (1H, d,J = 12 Hz, H-3'), 
7.64 - 7.92 (10H, m, phenyl), 8.38 (1H, d,J = 7.8 
Hz, H-1'), 11.00 (1H, s, COOH); 13C-NMR (100 
MHz, CDCl3, δ / ppm): 56.8 (-CH3), 108.4 (C5), 
109.1 (C3), 112.6 (C1), 119.8 (C2'), 126.1 (C5'& 
C9'), 127.2 (C7'), 128.6 (C6'& C8'), 132.4 (C2), 
135.7 (C4'), 138.3 (C3'), 150.5 (C4), 163.2 (C1'), 
167.8 (C6) , 169.6 (-COOH); MS (m/z, (relative 
abundance, %)): 281 (M+, 20.7), 204, 151, 130, 




6): Yield: 86 %; mp: 130-140 ºC; Anal. Calcd. for 
C16H13NO2: C, 76.42; H, 5.29 N, 5.52 %. Found  
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 Table 2: Minimum inhibitory concentration (MIC) of β-phenyl acrolein derivatives, SB-1 to SB-6 
 
 Minimum inhibitory concentration (MIC, µg/mL) Compound Gram positive bacteria    Gram negative bacteria 
  B. subtilis S. aureus P. aeruginosa K. pneumoniae 
SB-1 250 62.5 250 250 
SB-2 125 62.5 125 250 
SB-3 62.5 62.5 250 250 
SB-4 125 62.5 62.5 250 
SB-5 125 62.5 62.5 62.5 
SB-6 125 62.5 62.5 62.5 
 
Table 3: Zone of inhibition of β-phenyl acrolein derivatives, SB-1 to SB-6 
Compound 
  
Zone of inhibition (mm, 250µg/mL) 
Gram positive bacteria                Gram negative bacteria 
B. subtilis S. aureus P. aeruginosa K. pneumoniae 
SB-1 8.5±0.28 9.9±0.57* 8.6 ±0.33 7.8±0.17 
SB-2 10.1±0.72 10.8±0.92* 7.3±0.33 7.3±0.67 
SB-3 12.0± 0.57* 10.0±1.00* 8.3±0.33 7.3±0.33 
SB-4 9.6±0.33 10.6 ±0.33* 10.3±0.33* 6.3±0.33 
SB-5 10.3±0.33 11.3 ±0.33* 10.6 ± 0.33* 12.0+0.10* 
SB-6 9.6±0.33 10.3 ±0.88* 11.6± 0.88* 12.3±0.57* 
Gentamicin 12.3±0.33 9.3±0.57 10.0 ±0.57 12.6±0.67 
*p˂0.05, compared to Gentamycin (one-way ANOVA followed by Dunnett’s multiple comparison test (p < 0.05.); 
values are mean ± SEM (n = 3) 
 
C, 72.51; H, 5.32N, 4.88 %; IR (KBr cm-1): 3052 
(=C-H stretching of aromatic ring), 3036 (=C-H 
stretching of alkenyl group), 2926, 2872 (C-H 
stretching of methyl group), 1668 (-C=N 
stretching azomethine group), 1540-1600 (C=C- 
stretching of aromatic ring), 1320 (C-N, 
stretching of azomethine group); 1H-NMR (500.1 
MHz, CDCl3-d,δ/ppm): 5.85 (1H, t, J = 9.5 Hz, H-
2'), 6.76 (1H, d, J = 12 Hz, H-3'), 7.64 - 7.92 
(10H, m,phenyl), 8.41 (1H, d, J = 7.8 Hz, H-1'), 
11.00 (1H, s, COOH); 13C-NMR (100 MHz, 
CDCl3, δ / ppm): 120.4 (C2'), 123.5 (C3& C5), 
126.7 (C5'& C9'), 127.4 (C7'), 128.4 (C6'& C8'), 
129.2 (C1), 131.2 (C2& C6), 135.9 (C4'), 139.4 
(C3'), 155.4 (C4), 164.8 (C1'), 169.6 (-COOH); MS 
(m/z, (relative abundance, %)): 251 (M+, 32.6), 
174, 130, 121, 102, 77, 53, 51 (BP, 100); UV-Vis 




The newly synthesized β-phenyl acrolein 
derivatives were tested for their antibacterial 
potential against B. subtilis and S. aureus, K. 
pneumoniae, and P. aeruginosa, using 
gentamycin as standard. The results are given in 




Equimolar concentration of β-phenyl acrolein and 
substituted aromatic amines in the presence of 
basic catalyst, triethylamine resulted in formation 
of azomethine derivatives of β-phenyl acrolein 
moiety shown in Figure 1. 
 
The λmax for the newly synthesized azomethines 
was found to be in range from 300-440 nm. The 
IR stretch at around 1650-1680 cm-1 showed the 
C=N bond formation. The formation of 
azomethines was identified by the presence of 
triplet between 5.7 to 5.8 ppm, in proton NMR 
spectra. All other aliphatic and aromatic protons 
were observed within the expected regions. The 
novel compounds were further confirmed by their 
characteristic mass fragment spectra. The mass 
fragment pattern of compound SB-4 given in 
Figure 2, displayed parent ion peak at 237, base 
peak at 51, and different fragment peaks at 160, 
130, 107, 102, 77, and 53. 
 
Similarly, all the new compounds were 
characterized. This part confirmed the synthesis 
of a series of six new azomethines derivatives of 
β-phenyl acrolein. 
 
The antibacterial potential of newly synthesized 
molecules was estimated by tube dilution and 
disc diffusion method; using Gram positive 
bacteria (Bacillus subtilis and Staphylococcus 
aureus) and Gram negative bacteria (Klebsiella 
pneumoniae and Pseudomonas aeruginosa). 
Tube dilution method depends upon the inhibition 
of growth of a microbial culture in a uniform 
solution of antibiotic in a fluid medium that is 
favorable to its rapid growth in the absence of the 
antibiotic [17]. In this method minimum inhibitory  
Chigurupati et al 




































           R1 = -H,         R2 = -H,      R3 = -H,         for SB-1
           R2 = -CHO,   R2 = -H,      R3 = -H,         for SB-2
           R1 = -OH,      R2 = -H,      R3 = -H,         for SB-3
           R1 = -OCH3,    R2 = -H,      R3 = -H,         for SB-4
           R1 = -H,         R2 = -OCH3, R3 = -COOH,   for SB-5
           R1 = -COOH,  R2 = -H,      R3 = -H,          for SB-6  















































Figure 2: Mass fragmentation pattern of SB-4 
 
concentration of the test compounds was 
determined. Gentamycin was used as a standard 
drug [18]. 
 
As per the minimum inhibitory concentration 
study results given in Table 2 and Table 3, 
among all synthesized compounds, SB-5 and 
SB-6 displayed highest MIC value of 62.5 µg/ml. 
The zone of inhibition experiment, revealed that 
at MIC of 250 µg/ml, all compounds SB-1 to SB-
6 showed significant antibacterial activity (p < 
0.05). SB-5 and SB-6 were active against S. 
aureus, P. aeruginosa and K. pneumoniae; SB-3 
was active against B. subtilis and S. aureus, SB-
4 was active against P. aeruginosa and S. 
aureus. SB-1 and SB-2 were active against S. 
aureus. The antimicrobial results proved that all 
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synthesized azomethines of β-phenyl acrolein 




β-Phenyl acrolein derivatives have been 
successfully synthesized and appear to be a 
novel and important class of antibacterial agents 
against Gram-positive and Gram-negative 
bacteria including S. aureus, P. aeruginosa, and 
K. pneumonia. The synthetic route and 
antibacterial potential of the compounds may be 
useful in guiding future efforts to synthesize new 
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